Thu, Sep 18, 2014, 11:37 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • jetmanbash jetmanbash Aug 11, 2014 4:35 PM Flag

    Need more funding:

    I was highly criticized before when I noted that they would need more funding....and guess they will. You aren't going to be getting a pediatric indication without spending at least three times as much as they did in regards to the adult indication. Also, Mr. Beer is going to want to do more studies to see if he can dig up more people under the heading of HoF. You also have still continued loses, legal expenses, and possibly large penalties. All hidden under the guise of the money might be used for further expanding investments. They also say that they are going to be buying back stock......Is that wise for a growing biotech to do? IMO it isn't, valuable dollars should be spent trying to grow the company. A lot of trickery, hope the CEO paid out of pocket when he had the huge celebration at the Waldorf-Astoria when the announcement was made for approval. It has been all down hill since. t

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • should have followed Perceptive Advisors; they bought from 15-28 and sold all at $89.2. Rest of us bought high and rode it down to a current trap at 30. that's why they are rich and we are poor because we never know when to buy and when to fold. follow big money...

    • Ridiculous - you still haven't looked up the cost of an Orphan Drug pediatric study. Simply put: The $300M is, certainly, not for the upcoming Juxtapid pediatric study. $AEGR is, clearly, in the market to buy something, and it will be doing it without directly diluting shares, which is what you said they would do. Guess AEGR won't be a one hit wonder thereafter, will it? Also, AEGR is making money and you said it would not do so. Silly out of touch, Jetmanbash (with six known IDs).

      Sentiment: Buy

 
AEGR
34.10+0.41(+1.22%)Sep 18 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Oracle Corporation
NYSEThu, Sep 18, 2014 4:04 PM EDT
Concur Technologies, Inc.
NasdaqGSThu, Sep 18, 2014 4:00 PM EDT
Rite Aid Corporation
NYSEThu, Sep 18, 2014 4:02 PM EDT